Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial.

Front Cardiovasc Med · 2021 · PMC8364959 · PMID 34409082

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

borderline significantP = 0.054so close (0.05 < p ≤ 0.1)

The distribution of MBG was borderline significant in favor of patients randomized to the pro-UK and tirofiban groups ( P = 0.054).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.